Back
Essilorluxottica Vs. Innate Pharma SA Industry Stock Comparison
Buy
75
ESLOY
Essilorluxottica
Last Price:
113.14
Seasonality Move:
4.1%
Sell
42
IPHA
Innate Pharma SA
Last Price:
2.51
Seasonality Move:
-8.23%
Buy
75
Essilorluxottica (ESLOY)
is a Buy
Is Essilorluxottica a Buy, Sell or Hold?
- The current Essilorluxottica [ESLOY] share price is $111.44. The Score for ESLOY is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ESLOY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $2.64. The Score for IPHA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESLOY Stock Price Chart
What is Essilorluxottica's stock price today?
-
The Essilorluxottica share price today is $111.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESLOY is experiencing slight buying pressure.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESLOY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 57.91 | Buy |
| Chaikin Money Flow: | 7381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.55 - 110.19) | Buy |
| Bollinger Bands (100): | (99.75 - 111.37) | Buy |
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 55.89 | Buy |
| Chaikin Money Flow: | 10369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.38 - 2.56) | Buy |
| Bollinger Bands (100): | (2.45 - 2.73) | Buy |
ESLOY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.88 | Buy |
| 20-day SMA: | 109.05 | Buy |
| 50-day SMA: | 110.69 | Buy |
| 200-day SMA: | 99.42 | Buy |
| 8-day EMA: | 110.25 | Buy |
| 20-day EMA: | 109.65 | Buy |
| 50-day EMA: | 108.79 | Buy |
| 200-day EMA: | 101.69 | Buy |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.57 | Buy |
| 20-day SMA: | 2.47 | Buy |
| 50-day SMA: | 2.5 | Buy |
| 200-day SMA: | 2.61 | Buy |
| 8-day EMA: | 2.56 | Buy |
| 20-day EMA: | 2.51 | Buy |
| 50-day EMA: | 2.52 | Buy |
| 200-day EMA: | 2.63 | Buy |
Essilorluxottica Earnings Growth & ESLOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Essilorluxottica Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Innate Pharma SA Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||